
Transcriptome-based identification of lovastatin as a breast cancer stem cell-targeting drug.

Transcriptome-based identification of lovastatin as a breast cancer stem cell-targeting drug.
An international comparative analysis and roadmap to sustainable biosimilar markets. VER MÁS
Development and validation of a mass spectrometric method to determine the identity of rituximab based on its microheterogeneity profile....
Fecha de publicación: 20 Septiembre 2019 Utilization of naproxen by Amycolatopsis sp. Poz 14 and detectionof the enzymes involved...
The yin/yang of inflammatory status: Blood-brain barrier regulation during sleep. VER MÁS
Fecha de publicación: Marzo 2021 Poor survival in COVID-19 associated with Lymphopenia and Higher Neutrophile-Lymphocyte ratio Ver más
Development of Functional Antibodies Directed to Human Dialyzable Leukocyte Extract (Transferon®). VER MÁS
Fecha de publicación: 10 de abril de 2019 CD80 Expression Correlates with IL-6 Production in THP-1-Like Macrophages Costimulated with...

+52 (55) 5729 6000 Ext. 62543
Escuela Nacional de Ciencias Biológicas. Prolongación de Carpio y Plan de Ayala S/N, Del. Miguel Hidalgo, CDMX, C.P. 11340.
©2026 UDIBI